Check out our latest #research on ADP-ribosylation signaling, published in@NatureComms and led by our former PhD student @ELongarini! 🥳 https://t.co/EBwSTThqMX
We are happy to share that our latest study on ADP-ribosyl-linked serine ubiquitylation in the context of PARP1 signaling and the DNA damage response is out in Nature Chemical Biology! 🥂🎉☺️
https://t.co/j8g6bed6TI
These new antibody development efforts align with our vision that the fundamental discovery of Serine ADP-ribosylation can be converted into a technology that transforms the study of ADP-ribosylation and related PTMs.
We’ve uploaded a bioRxiv preprint on new antibodies specific for poly-ADP-ribosylation (PARylation). These modular tools were developed and validated through novel applications of our Serine ADP-ribosylation-based technology.
https://t.co/SMgJuRbSMm
This preprint is part of a larger manuscript on additional antibodies and their applications to biological questions. The goal of this preprint is to share these poly-ADPr with the community without delay, as we believe they will benefit many laboratories.
Last week we had the pleasure of hosting Professor Lee Kraus from UT Southwestern in Texas. After an insightful talk @MPIAGE and a fruitful round table discussions about science, industry and much in between, we continued our evening in a traditional German restaurant. 🍻
Our new paper describing how tyrosine-linked ADP-ribosylation signalling is reversed. Big thanks to our collaborators @JgmRack, @LeidenADPr and @Lab_Matic.
https://t.co/zAH5HWAO0U
SEMINAR: Discovery and development of Serine ADP-ribosylation, Dr Ivan Matić; Max Planck Institute for Biology of Ageing
Tuesday 17th September, 1.30-2.30pm
Details: https://t.co/W7fBYH3wK2
Last week two of our lab members attended the #NADSRC in sunny Lisbon ☀️🌊 Our Serine-ADPr technnology was showcased in a talk by our postdoc Helen, and she and our PhD student Mihaela presented it during two successful poster sessions! ☺️
🔬Biochemist Dr. Ivan Matić from the @MPIAGE
for Biology of Ageing has spoken at the @LeibnizFLI yesterday about the latest discoveries and developments of his research group on protein modification ADP-ribosylation.💡
@Lab_Matic#ScienceResearch#aging
https://t.co/ECVlQNmMvM
As mentioned some time ago, there is an opening for a mass spec specialist (post-doc) working between our lab and the metabolomics facility @CECAD_ to support the Bioanalytical Platform of @CRC1218, https://t.co/xTXWxXwnfK
Send your applications here: https://t.co/X0YFGQHifv
Outstanding scientists elected to EMBO Membership: in EMBO’s 60th anniversary year, 100 new members and 20 associate members join the community
https://t.co/eHCoXY0ynR
👏Double Congratulations!👏
Aleksandra Trifunovic and Ivan Matić have been elected new @EMBO members for their pioneering science in mitochondrial biology and protein modifications! 🎉
@AleXTrifunovic@Lab_Matic@UniCologne@MPIAGE#EMBOmembers
https://t.co/JA925K4EUV